{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:09:33Z","timestamp":1792292973499,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ymgme.2020.12.288","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T23:42:46Z","timestamp":1608162166000},"page":"44-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Gaucher disease and SARS-CoV-2 infection: Experience from 181 patients in New York"],"prefix":"10.1016","volume":"132","author":[{"given":"Luca","family":"Fierro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Nesheiwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hetanshi","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveena","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod K.","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Balwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.ymgme.2020.12.288_bb0005","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA."},{"issue":"10239","key":"10.1016\/j.ymgme.2020.12.288_bb0010","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0140-6736(20)31189-2","article-title":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study","volume":"395","author":"Cummings","year":"2020","journal-title":"Lancet."},{"issue":"3","key":"10.1016\/j.ymgme.2020.12.288_bb0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ymgme.2020.05.002","article-title":"Gaucher disease and SARS-CoV-2 infection: emerging management challenges","volume":"130","author":"Mistry","year":"2020","journal-title":"Mol. Genet. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2020.12.288_bb0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ymgme.2016.11.006","article-title":"Gaucher disease: Progress and ongoing challenges","volume":"120","author":"Mistry","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2020.12.288_bb0025","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0950-3536(97)80033-9","article-title":"Gaucher\u2019s disease: clinical features and natural history","volume":"10","author":"Cox","year":"1997","journal-title":"Baillieres Clin Haematol."},{"issue":"7643","key":"10.1016\/j.ymgme.2020.12.288_bb0030","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature21368","article-title":"Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease","volume":"543","author":"Pandey","year":"2017","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.ymgme.2020.12.288_bb0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/17474086.2016.1112732","article-title":"Hematological manifestations and complications of Gaucher disease","volume":"9","author":"Linari","year":"2016","journal-title":"Expert. Rev. Hematol."},{"key":"10.1016\/j.ymgme.2020.12.288_bb0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.smim.2018.02.006","article-title":"An unexpected player in Gaucher disease: the multiple roles of complement in disease development","volume":"37","author":"Pandey","year":"2018","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.ymgme.2020.12.288_bb0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/acel.12409","article-title":"Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages","volume":"15","author":"Aflaki","year":"2016","journal-title":"Aging Cell"},{"issue":"3","key":"10.1016\/j.ymgme.2020.12.288_bb0050","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12250-020-00207-4","article-title":"Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools","volume":"35","author":"Fu","year":"2020","journal-title":"Virol. Sin."},{"key":"10.1016\/j.ymgme.2020.12.288_bb0055","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","article-title":"SARS-CoV-2 infection: the role of cytokines in COVID-19 disease","volume":"54","author":"Costela-Ruiz","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"9","key":"10.1016\/j.ymgme.2020.12.288_bb0060","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/ajh.25875","article-title":"Real-world effectiveness of eliglustat in treatment-na\u00efve and switch patients enrolled in the International Collaborative Gaucher Group Gaucher Registry","volume":"95","author":"Mistry","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"9","key":"10.1016\/j.ymgme.2020.12.288_bb0065","article-title":"Enzyme replacement and substrate reduction therapy for Gaucher disease","volume":"2015","author":"Shemesh","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"issue":"S1","key":"10.1016\/j.ymgme.2020.12.288_bb0070","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1002\/ajh.24056","article-title":"Long-term treatment outcomes in Gaucher disease","volume":"90","author":"Charrow","year":"2015","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.ymgme.2020.12.288_bb0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9610(91)90363-I","article-title":"A 27-year experience with splenectomy for Gaucher\u2019s disease","volume":"161","author":"Fleshner","year":"1991","journal-title":"Am. J. Surg."},{"issue":"2","key":"10.1016\/j.ymgme.2020.12.288_bb0080","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.ymgme.2020.12.288_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J. Biomed. Inform."},{"issue":"4","key":"10.1016\/j.ymgme.2020.12.288_bb0090","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10545-009-9009-6","article-title":"Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry","volume":"33","author":"Tylki-Szyma\u0144ska","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2020.12.288_bb0095","doi-asserted-by":"crossref","DOI":"10.1089\/gte.1997.1.5","article-title":"Gaucher disease: Gene frequencies and genotype\/phenotype correlations","volume":"1","author":"Grabowski","year":"1997","journal-title":"Genet Test."},{"key":"10.1016\/j.ymgme.2020.12.288_bb0100","article-title":"SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months","author":"Wajnberg","year":"2020","journal-title":"medRxiv"},{"issue":"18","key":"10.1016\/j.ymgme.2020.12.288_bb0105","first-page":"1824","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review","volume":"323","author":"Sanders","year":"2020","journal-title":"JAMA - J Am Med Assoc."},{"issue":"7","key":"10.1016\/j.ymgme.2020.12.288_bb0110","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/imj.14894","article-title":"Impact of Gaucher disease on COVID-19","volume":"50","author":"Zimran","year":"2020","journal-title":"Intern. Med. J."},{"issue":"3","key":"10.1016\/j.ymgme.2020.12.288_bb0115","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ymgme.2020.04.002","article-title":"Impact of COVID-19 related healthcare crisis on treatments for patients with lysosomal storage disorders, the first Italian experience","volume":"130","author":"Sechi","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.12.288_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2020.102478","article-title":"Direct and indirect effects of the SARS-CoV-2 pandemic on Gaucher disease patients in Spain: time to reconsider home-based therapies?","volume":"85","author":"Andrade-Campos","year":"2020","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ymgme.2020.12.288_bb0125","article-title":"Antiviral activity of Glucosylceramide synthase inhibitors against SARS-CoV-2 and other RNA virus infections","author":"Vitner","year":"2020","journal-title":"bioRxiv"},{"issue":"8","key":"10.1016\/j.ymgme.2020.12.288_bb0130","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1182\/blood-2014-09-600270","article-title":"Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation","volume":"125","author":"Nair","year":"2015","journal-title":"Blood."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220305576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220305576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:26:51Z","timestamp":1761089211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719220305576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1096719220305576"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.12.288","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gaucher disease and SARS-CoV-2 infection: Experience from 181 patients in New York","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.12.288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}